- Home
- Publications
- Publication Search
- Publication Details
Title
Rise of TRIM8: A Molecule of Duality
Authors
Keywords
E3 ubiquitin ligases, TRIM family, TRIM8, cancer
Journal
Molecular Therapy-Nucleic Acids
Volume 22, Issue -, Pages 434-444
Publisher
Elsevier BV
Online
2020-09-03
DOI
10.1016/j.omtn.2020.08.034
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TRIM8 interacts with KIF11 and KIFC1 and controls bipolar spindle formation and chromosomal stability
- (2020) Santina Venuto et al. CANCER LETTERS
- TRIM proteins in autophagy: selective sensors in cell damage and innate immune responses
- (2020) Martina Di Rienzo et al. CELL DEATH AND DIFFERENTIATION
- Inhibition of TRIM8 restrains ischaemia-reperfusion-mediated cerebral injury by regulation of NF-κB activation associated inflammation and apoptosis
- (2020) Xue Bai et al. EXPERIMENTAL CELL RESEARCH
- TNFAIP3 Interacting Protein 3 Overexpression Suppresses Nonalcoholic Steatohepatitis by Blocking TAK1 Activation
- (2020) Dan Liu et al. Cell Metabolism
- Association of a de novo nonsense mutation of the TRIM8 gene with childhood-onset focal segmental glomerulosclerosis
- (2020) Mikako Warren et al. PEDIATRIC NEPHROLOGY
- Suppression of TRIM8 by microRNA-182-5p restricts tumor necrosis factor-α-induced proliferation and migration of airway smooth muscle cells through inactivation of NF-Κb
- (2020) Xiaomin Dang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Targeting Chemoresistant Tumors: Could TRIM Proteins-p53 Axis Be a Possible Answer?
- (2019) Valletti et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- E3 Ubiquitin Ligase TRIM Proteins, Cell Cycle and Mitosis
- (2019) Venuto et al. Cells
- TRIM8 is required for virus-induced IFN response in human plasmacytoid dendritic cells
- (2019) Ghizlane Maarifi et al. Science Advances
- TRIM8 Blunts the Pro-proliferative Action of ΔNp63α in a p53 Wild-Type Background
- (2019) Mariano Francesco Caratozzolo et al. Frontiers in Oncology
- Downregulation of TRIM8 protects neurons from oxygen–glucose deprivation/re-oxygenation-induced injury through reinforcement of the AMPK/Nrf2/ARE antioxidant signaling pathway
- (2019) Wei Zhao et al. BRAIN RESEARCH
- TRIM8 regulated autophagy modulates the level of cleaved Caspase-3 subunit to inhibit genotoxic stress induced cell death
- (2018) Milton Roy et al. CELLULAR SIGNALLING
- The molecular basis of JAK/STAT inhibition by SOCS1
- (2018) Nicholas P. D. Liau et al. Nature Communications
- Further delineation of the clinical spectrum of de novo TRIM8 truncating mutations
- (2018) Mirna Assoum et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- TRIM8-driven transcriptomic profile of neural stem cells identified glioma-related nodal genes and pathways
- (2018) Santina Venuto et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- KIF11 silencing and inhibition induces chromosome instability that may contribute to cancer
- (2017) Yasamin Asbaghi et al. GENES CHROMOSOMES & CANCER
- TRIM8 Negatively Regulates TLR3/4-Mediated Innate Immune Response by Blocking TRIF–TBK1 Interaction
- (2017) Wen Ye et al. JOURNAL OF IMMUNOLOGY
- TRIM8 restores p53 tumour suppressor function by blunting N-MYC activity in chemo-resistant tumours
- (2017) Francesca Mastropasqua et al. Molecular Cancer
- TRIM8 regulates stemness in glioblastoma through PIAS3-STAT3
- (2017) Changming Zhang et al. Molecular Oncology
- TRIM Family Proteins: Roles in Autophagy, Immunity, and Carcinogenesis
- (2017) Shigetsugu Hatakeyama TRENDS IN BIOCHEMICAL SCIENCES
- miR-182 promotes tumor growth and increases chemoresistance of human anaplastic thyroid cancer by targeting tripartite motif 8
- (2017) Yao Liu et al. OncoTargets and Therapy
- TRIM8: Making the Right Decision between the Oncogene and Tumour Suppressor Role
- (2017) Mariano Caratozzolo et al. Genes
- De NovoTruncating Mutation ofTRIM8Causes Early-Onset Epileptic Encephalopathy
- (2016) Yasunari Sakai et al. ANNALS OF HUMAN GENETICS
- Drugging the undruggables: exploring the ubiquitin system for drug development
- (2016) Xiaodong Huang et al. CELL RESEARCH
- Tripartite Motif 8 (TRIM8) Positively Regulates Pro-inflammatory Responses in Pseudomonas aeruginosa-Induced Keratitis Through Promoting K63-Linked Polyubiquitination of TAK1 Protein
- (2016) Litao Guo et al. INFLAMMATION
- Ubiquitin chain diversity at a glance
- (2016) Masato Akutsu et al. JOURNAL OF CELL SCIENCE
- TRIM8 downregulation in glioma affects cell proliferation and it is associated with patients survival
- (2015) Lucia Micale et al. BMC CANCER
- A phenotypic screen identifies microtubule plus end assembly regulators that can function in mitotic spindle orientation
- (2015) Ailine Stolz et al. CELL CYCLE
- The mitotic kinesin KIF11 is a driver of invasion, proliferation, and self-renewal in glioblastoma
- (2015) Monica Venere et al. Science Translational Medicine
- TRIM8 anti-proliferative action against chemo-resistant renal cell carcinoma
- (2015) Mariano Francesco Caratozzolo et al. Oncotarget
- TRIM8 modulates p53 activity to dictate cell cycle arrest
- (2012) Mariano Francesco Caratozzolo et al. CELL CYCLE
- The miR-17∼92 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes
- (2012) R Bomben et al. LEUKEMIA
- Nucleo-Cytoplasmic Trafficking of TRIM8, a Novel Oncogene, Is Involved in Positive Regulation of TNF Induced NF-κB Pathway
- (2012) Dhanendra Tomar et al. PLoS One
- Tripartite motif 8 (TRIM8) modulates TNF - and IL-1 -triggered NF- B activation by targeting TAK1 for K63-linked polyubiquitination
- (2011) Q. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting the Kinesin Spindle Protein: Basic Principles and Clinical Implications
- (2008) V. Sarli et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started